XML 31 R20.htm IDEA: XBRL DOCUMENT v3.25.2
Stockholders’ Equity (Tables)
6 Months Ended
Jun. 30, 2025
Stockholders’ Equity [Abstract]  
Schedule of Estimated Using the Black-Scholes Option-Pricing Model

The fair value of the January 2023 Existing Warrants on the modification date was estimated using the Black-Scholes option-pricing model with the following assumptions:

 

   March 27,
2024 to
April 1,
2024
 
Exercise price  $ 1.50 to $5.00 
Term (years)   4.25 
Expected stock price volatility   109.8%
Risk-free rate of interest   4.18% to 4.34% 

The fair value of option grants was estimated on the date of grant using the Black-Scholes option-pricing model with the following assumptions:

 

   June 4, 2025 
Exercise price  $1.00 
Term (years)   2.0 
Expected stock price volatility   129.68%
Risk-free rate of interest   3.87%
Schedule of Warrant Activity

A summary of warrant activity for the six months ended June 30, 2025 is as follows:

 

   Number of
Warrants
   Weighted
Average
Exercise
Price
   Total
Intrinsic
Value
   Weighted
Average
Remaining
Contractual Life
(in years)
 
Outstanding as of December 31, 2024   5,203,243   $2.62    
    3.52 
Granted   300,000    1.00         
Expired   (12,491)   55.96    
     
Exercised   (3,750,000)   1.50    
     
Outstanding as of June 30, 2025   1,740,752    4.38    51,000    2.88 
Warrants exercisable as of June 30, 2025   1,740,752   $4.38   $51,000    2.88 
Schedule of Restricted Stock Awards Granted

A summary of the Company’s restricted stock awards granted under the equity incentive plans during the three months ended June 30, 2025 and 2024 is as follows:

 

   For the Six Months Ended June 30, 2025   For the Six Months Ended June 30, 2024 
   Number of
Restricted Stock
Awards
   Weighted
Average Grant
Date Fair Value
   Number of
Restricted Stock
Awards
   Weighted
Average Grant
Date Fair Value
 
Nonvested at beginning of period   
    
    1,693    3.16 
Vested   
    
    
    
 
Nonvested at end of period   
    
    1,693    3.16 
Schedule of Black-Scholes Option-pricing Model Assumptions

The fair value of option grants was estimated on the date of grant using the Black-Scholes option-pricing model with the following assumptions:

 

   Six Months Ended
June 30,
 
   2025   2024 
Exercise price  $1.55   $1.36 
Term (years)   5.0    5.0 
Expected stock price volatility   118.32%   120.00%
Risk-free rate of interest   4.59%   4.02%
Schedule of Option Activity

A summary of option activity under the Company’s equity incentive plans for the six months ended June 30, 2025 is presented below.

 

   Number of
Shares
   Weighted
Average
Exercise
Price
   Total
Intrinsic
Value
   Weighted
Average
Remaining
Contractual
Life
(in years)
 
Outstanding as of December 31, 2024   1,090,362   $4.78   $
    9.1 
Employee options issued   170,000    1.55    
     
Outstanding as of June 30, 2025   1,260,362   $4.34   $196,390    8.7 
Options vested and exercisable as of June 30, 2025   1,260,362   $4.34   $196,390    8.7 
Schedule of Stock Options Outstanding

A summary of stock options outstanding at June 30, 2025 by price range is as follows:

 

   Options outstanding and exercisable 
Range of Exercise Prices  Number of
Shares
   Weighted
Average
Remaining
Contractual
Life
(in years)
   Weighted
Average
Exercise
Price
 
Up to $2.59   1,183,000    8.8   $1.24 
$14.75 to $76.25   62,562    6.2   $32.95 
Above $76.25   14,800    4.5   $131.50 
Options outstanding and exercisable as of June 30, 2025   1,260,362    8.7   $4.34 
Schedule of Stock-Based Compensation Expense

Stock-based compensation expense for the three and six months ended June 30, 2025 and 2024 was as follows:

 

   Three Months Ended
June 30,
   Six Months Ended
June 30,
 
   2025   2024   2025   2024 
Employee stock option awards  $
   $
   $219,929   $512,685 
Non-employee restricted stock awards   
    665    
    1,330 
Non-employee stock warrant awards   55,525    6,389    55,525    6,389 
   $55,525   $7,054   $275,454   $520,404 
Schedule of Stock-Based Compensation Expense Included Within Research and Development, Professional Fees and General and Administrative Expenses

For the three and six months ended June 30, 2025 and 2024, the amount of stock-based compensation expense included within research and development, professional fees and general and administrative expenses was as follows:

 

   Three Months Ended
June 30,
   Six Months Ended
June 30,
 
   2025   2024   2025   2024 
Research and development  $
   $6,389   $
   $6,389 
Professional fees   55,525    
    55,525    
 
General and administrative   
    665    219,929    514,015 
   $55,525   $7,054   $275,454   $520,404